These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29606083)

  • 1. Carbohydrate-based heteronuclear complexes as topoisomerase Iα inhibitor: approach toward anticancer chemotherapeutics.
    Afzal M; Al-Lohedan HA; Usman M; Tabassum S
    J Biomol Struct Dyn; 2019 Apr; 37(6):1494-1510. PubMed ID: 29606083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activity}.
    Afsan Z; Roisnel T; Tabassum S; Arjmand F
    Bioorg Chem; 2020 Jan; 94():103427. PubMed ID: 31735357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of heterobimetallic Sn
    Afzal M; Usman M; Al-Lohedan HA; Tabassum S
    J Biomol Struct Dyn; 2020 Mar; 38(4):1130-1142. PubMed ID: 30885099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of Cu(II)-based anticancer chemotherapeutic agent targeting topoisomerase Iα: in vitro DNA binding, pBR322 cleavage, molecular docking studies and cytotoxicity against human cancer cell lines.
    Tabassum S; Zaki M; Afzal M; Arjmand F
    Eur J Med Chem; 2014 Mar; 74():509-23. PubMed ID: 24508781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
    Tabassum S; Zaki M; Afzal M; Arjmand F
    Dalton Trans; 2013 Jul; 42(27):10029-41. PubMed ID: 23715526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New heterobimetallic Cu(II)-Sn2(IV) complex as potential topoisomerase I inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines.
    Tabassum S; Afzal M; Arjmand F
    J Photochem Photobiol B; 2012 Oct; 115():63-72. PubMed ID: 22884481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular drug design, synthesis and crystal structure determination of CuII-SnIV heterobimetallic core: DNA binding and cleavage studies.
    Arjmand F; Parveen S; Afzal M; Toupet L; Ben Hadda T
    Eur J Med Chem; 2012 Mar; 49():141-50. PubMed ID: 22305542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of heterobimetallic topoisomerase I and II inhibitor complexes: in vitro DNA binding, interaction with 5'-GMP and 5'-TMP and cleavage studies.
    Arjmand F; Muddassir M
    J Photochem Photobiol B; 2010 Oct; 101(1):37-46. PubMed ID: 20638859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate linked organotin(IV) complexes as human topoisomerase Iα inhibitor and their antiproliferative effects against the human carcinoma cell line.
    Khan RA; Yadav S; Hussain Z; Arjmand F; Tabassum S
    Dalton Trans; 2014 Feb; 43(6):2534-48. PubMed ID: 24310209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of new transition metal {Cu(II), Ni(II) and Co(II)} L-phenylalanine-DACH conjugate complexes: in vitro DNA binding, cleavage and molecular docking studies.
    Shamsi M; Yadav S; Arjmand F
    J Photochem Photobiol B; 2014 Jul; 136():1-11. PubMed ID: 24815057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the DNA binding/cleavage, cellular accumulation and topoisomerase inhibition of 2-hydroxy-3-(aminomethyl)-1,4-naphthoquinone Mannich bases and their platinum(II) complexes.
    Neves AP; Pereira MX; Peterson EJ; Kipping R; Vargas MD; Silva FP; Carneiro JW; Farrell NP
    J Inorg Biochem; 2013 Feb; 119():54-64. PubMed ID: 23186648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structures, nuclease activity, cytotoxicity, DFT and molecular docking studies of two nitrato bridged homodinuclear (Cu-Cu, Zn-Zn) complexes containing 2,2'-bipyridine and a chalcone derivative.
    Gaur R; Choubey DK; Usman M; Ward BD; Roy JK; Mishra L
    J Photochem Photobiol B; 2017 Aug; 173():650-660. PubMed ID: 28711020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New modulated design, docking and synthesis of carbohydrate-conjugate heterobimetallic CuII-SnIV complex as potential topoisomerase II inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines.
    Tabassum S; Afzal M; Arjmand F
    Eur J Med Chem; 2014 Mar; 74():694-702. PubMed ID: 24268597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure elucidation of a cobalt(II) complex as topoisomerase I inhibitor: in vitro DNA binding, nuclease and RBC hemolysis.
    Ahmad M; Afzal M; Tabassum S; Kalińska B; Mrozinski J; Bharadwaj PK
    Eur J Med Chem; 2014 Mar; 74():683-93. PubMed ID: 24287075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral heterobimetallic complexes targeting human DNA-topoisomerase Iα.
    Tabassum S; Asim A; Khan RA; Hussain Z; Srivastav S; Srikrishna S; Arjmand F
    Dalton Trans; 2013 Dec; 42(48):16749-61. PubMed ID: 24077532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
    Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
    Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel phosphine sulphide gold(i) complexes: topoisomerase I inhibitors and antiproliferative agents.
    Martín-Encinas E; Conejo-Rodríguez V; Miguel JA; Martínez-Ilarduya JM; Rubiales G; Knudsen BR; Palacios F; Alonso C
    Dalton Trans; 2020 Jun; 49(23):7852-7861. PubMed ID: 32463416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, structural characterization, QSAR and docking studies of a new binuclear nickel (II) complex based on the flexible tetradentate N-donor ligand as a potent antibacterial and anticancer agent.
    Beheshti A; Hashemi F; Behavndi F; Zahedi M; Kolahi M; Motamedi H; Mayer P
    Int J Biol Macromol; 2017 Nov; 104(Pt A):1107-1123. PubMed ID: 28663150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
    Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
    Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, crystal structure and antiproliferative mechanisms of 2-acetylpyridine-thiosemicarbazones Ga(III) with a greater selectivity against tumor cells.
    Qi J; Zheng Y; Qian K; Tian L; Zhang GX; Cheng Z; Wang Y
    J Inorg Biochem; 2017 Dec; 177():110-117. PubMed ID: 28946027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.